96 related articles for article (PubMed ID: 30777785)
21. Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.
Makar-Aušperger K; Krželj K; Lovrić Benčić M; Radačić Aumiler M; Erdeljić Turk V; Božina N
Ther Drug Monit; 2018 Jun; 40(3):362-368. PubMed ID: 29494423
[TBL] [Abstract][Full Text] [Related]
22. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.
Zambon CF; Pengo V; Moz S; Bozzato D; Fogar P; Padoan A; Plebani M; Groppa F; De Rosa G; Padrini R
Eur J Clin Pharmacol; 2018 May; 74(5):571-582. PubMed ID: 29396738
[TBL] [Abstract][Full Text] [Related]
24. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
25. Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study).
Filippelli A; Signoriello S; Bancone C; Corbi G; Manzo V; Iesu S; Politi C; Gigantino A; De Donato MT; Masiello P; Simeon V; Della Corte A; Cellurale M; Conti V; Frigino M; Ciarambino T; Marracino M; Carpenito L; Ferrara N; De Feo M; Gallo C
Pharmacogenomics J; 2020 Jun; 20(3):451-461. PubMed ID: 31801992
[TBL] [Abstract][Full Text] [Related]
26. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
[TBL] [Abstract][Full Text] [Related]
27. Verification of five pharmacogenomics-based warfarin administration models.
Lin M; Yu L; Qiu H; Wang Q; Zhang J; Song H
Indian J Pharmacol; 2016; 48(3):258-63. PubMed ID: 27298494
[TBL] [Abstract][Full Text] [Related]
28. Application of Akaike information criterion to evaluate warfarin dosing algorithm.
Harada T; Ariyoshi N; Shimura H; Sato Y; Yokoyama I; Takahashi K; Yamagata S; Imamaki M; Kobayashi Y; Ishii I; Miyazaki M; Kitada M
Thromb Res; 2010 Sep; 126(3):183-90. PubMed ID: 20553802
[TBL] [Abstract][Full Text] [Related]
29. Clinical verification of Lou type warfarin pharmacokinetic dosing algorithms equation.
Jiang J; Ji N; Lan J; Ge X; Du X
Mol Med Rep; 2018 Apr; 17(4):6144-6149. PubMed ID: 29436624
[TBL] [Abstract][Full Text] [Related]
30. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
[TBL] [Abstract][Full Text] [Related]
31. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
An SH; Chang BC; Lee KE; Gwak HS
Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
[TBL] [Abstract][Full Text] [Related]
32. A systematic analysis and comparison of warfarin initiation strategies.
French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
[TBL] [Abstract][Full Text] [Related]
33. A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.
Duconge J; Ramos AS; Claudio-Campos K; Rivera-Miranda G; Bermúdez-Bosch L; Renta JY; Cadilla CL; Cruz I; Feliu JF; Vergara C; Ruaño G
PLoS One; 2016; 11(1):e0145480. PubMed ID: 26745506
[TBL] [Abstract][Full Text] [Related]
34. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
35. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
Voora D; Eby C; Linder MW; Milligan PE; Bukaveckas BL; McLeod HL; Maloney W; Clohisy J; Burnett RS; Grosso L; Gatchel SK; Gage BF
Thromb Haemost; 2005 Apr; 93(4):700-5. PubMed ID: 15841315
[TBL] [Abstract][Full Text] [Related]
36. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans.
Alzubiedi S; Saleh MI
J Cardiovasc Pharmacol; 2016 Jan; 67(1):86-92. PubMed ID: 26355760
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing for warfarin dosing? Not yet ready for prime time.
Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
[No Abstract] [Full Text] [Related]
39. Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty.
Xu H; Su S; Tang W; Wei M; Wang T; Wang D; Ge W
Thromb Res; 2015 Sep; 136(3):552-9. PubMed ID: 26188922
[TBL] [Abstract][Full Text] [Related]
40. Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.
Quinn AL; Liko I; Lee JC
Pharmacogenomics; 2017 Jul; 18(11):1051-1057. PubMed ID: 28685643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
